GM-CSF Upregulated in Rheumatoid Arthritis Reverses Cognitive Impairment and Amyloidosis in Alzheimer Mice

Rheumatoid arthritis (RA) is a negative risk factor for the development of Alzheimer’s disease (AD). While it has been commonly assumed that RA patients’ usage of non-steroidal anti-inflammatory drugs (NSAIDs) helped prevent onset and progression of AD, NSAID clinical trials have proven unsuccessful...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:J Alzheimers Dis
Autors principals: Boyd, Tim D., Bennett, Steven P., Mori, Takashi, Governatori, Nicholas, Runfeldt, Melissa, Norden, Michelle, Padmanabhan, Jaya, Neame, Peter, Wefes, Inge, Sanchez-Ramos, Juan, Arendash, Gary W., Potter, Huntington
Format: Artigo
Idioma:Inglês
Publicat: 2010
Matèries:
Article
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC5588158/
https://ncbi.nlm.nih.gov/pubmed/20555144
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3233/JAD-2010-091471
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars